EU regulator backs revoking Amgen's right to sell rare-disease drug - Reuters
EU regulator backs revoking Amgen's right to sell rare-disease drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxPQW1xek5kR0ljZzlCOUtEVnNfSWhSb2hVSVIxcTVGaWpoVllvaFF6VVhlNlRFNWtLWFFTc3lmcXpqZXZDOFk5UXFOZTdrTEdXS2diS0w0T21XWC1ZeVd1SUx2dXhTRU5HR1JGQUY3VTdKZlM5R2lzRFVDUl9KTVhmclRFSTV3aVU4MHBTd1BLZFRlM3NneUJkQTZXXzFmdm5rZFpfZmhUUkxpTWNiLVhOSVg5SkVqZ1RQSmNZSWY5YTI2TW5sX3NxOFk1bTU5TlpjZXhrUFI2TzRWZ2hE?oc=5" target="_blank">EU regulator backs revoking Amgen's right to sell rare-disease drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Boots has a new owner: Three ways it could affect you
The stalwart of Britain's High Street has been sold to a Canadian billionaire family. What will that mean for you?
October 9, 2026 at 11:01 PMUS FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMChina, EU strike deal to halve Chinese hybrid exports - Reuters
China, EU strike deal to halve Chinese hybrid exports Reuters
October 9, 2026 at 04:58 PMReport highlights flaws in ADHD and autism care
There is a risk of people being over-diagnosed with ADHD and autism, an official review in England has found.
October 9, 2026 at 01:52 PMHumana surges after topping 2027 Medicare star ratings - Reuters
Humana surges after topping 2027 Medicare star ratings Reuters
October 9, 2026 at 01:33 PMMost Medicare Advantage drug plan enrollees in high-quality plans, US government says - Reuters
Most Medicare Advantage drug plan enrollees in high-quality plans, US government says Reuters
October 8, 2026 at 11:29 PM